van Laar, J. A. (2024) “Expanding treatment options by selectively targeting the cytokine storm with ruxolitinib in primary hemophagocytic lymphohistiocytosis”, Haematologica. Pavia, Italy, 109(2), pp. 374-375. doi: 10.3324/haematol.2023.283915.